Crescent Biopharma Inc

crescentbiopharma.com

Crescent Biopharma Inc (NASDAQ: CBIO) is a biopharmaceutical company. The available filing excerpts from the 10-K filed 2026-02-26 (accession 000162828026011983) do not contain sufficient business description, revenue model, product, or operational detail to support a complete canonical description. No specific revenue figures, product names, pipeline assets, end markets, competitors, or geographic data are extractable from the provided excerpts.

Peers: AIM ImmunoTech Inc Jasper Therapeutics Inc Oruka Therapeutics Inc Vistagen Therapeutics Inc Harpoon Therapeutics, Inc. Pasithea Therapeutics Corp Vicapsys Life Sciences, Inc. Spruce Biosciences, Inc

Source: SEC 10-K, filed 2026-02-26

Dive deeper

Financial Snapshot

Revenue

TTM

$11.88M

Gross Margin

Last 4 Quarters

N/A

Net Income

TTM

-$167.1M

Current Assets

2026 Q2

$179.0M

Current Liabilities

2026 Q2

$18.54M

Current Ratio

2026 Q2

965.67%

Total Assets

2026 Q2

$182.8M

Total Liabilities

2026 Q2

$19.50M

Book Value

2026 Q2

$163.3M

Cash

2026 Q2

$171.6M

P/E

Last 4 Quarters

N/A

Free Cash Flow

TTM

-$126.1M

Stock Price

Market Cap: $608.42 Million